{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-294613","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2026-07-02T20:20:52+00:00","discovered_at":"2026-07-02T20:22:01.423250+00:00","generated_at":"2026-07-02T20:22:09.431145+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Pyxis Oncology raises $50M upfront in private placement; warrants could add $64M","bullets":["Gross proceeds of ~$50M from 19.6M shares at $2.551/share; warrants at $3.289 for additional ~$64M if exercised.","Financing led by BVF Partners with GordonMD, RTW Investments, Coastlands Capital; expected close July 2, 2026.","Proceeds extend cash runway into Q2 2027; support MICVO Phase 1 monotherapy and Phase 1/2 combination studies.","Updated Phase 1 monotherapy data for 2L+ R/M HNSCC expected Fall 2026; Phase 1/2 combo data in Q4 2026.","Warrants exercisable upon earlier of public disclosure of MICVO Phase 1 data or Oct 1, 2026; expire July 2, 2029."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-294613","json":"https://secwatch.observer/filing/0001193125-26-294613.json","markdown":"https://secwatch.observer/filing/0001193125-26-294613.md","text":"https://secwatch.observer/filing/0001193125-26-294613.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526294613/0001193125-26-294613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526294613/pyxs-20260630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:22:09.431145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}